ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/002935/06 Share code: APN ISIN: ZAE000066692 LEI: 635400ZYSN1IRD5QWQ94 (“Aspen” or “the Company”) ASPEN’S INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2022 AND RESULTS PRESENTATION REMINDER Shareholders are advised that Aspen intends releasing its results for the six months ended 31 December 2022 on the JSE Stock Exchange News Service on Wednesday, 1 March 2023. This will be followed by a live presentation to the investment community, in respect of these results, at 08h30 (SAST) on Thursday, 2 March 2023, that will be hosted at the Radisson Blu Hotel Waterfront, Cape Town. Interested stakeholders are also invited to watch the live presentation online by accessing the webcast link: https://www.corpcam.com/Aspen02032023 The slides accompanying the presentation will be available on the Aspen website, at https://www.aspenpharma.com shortly before the commencement of the presentation on 2 March 2023. A playback of the webcast will be made available on Aspen’s website approximately 2 hours after the presentation. Durban 17 February 2023 Sponsor: Investec Bank Limited